CTIS2023-507385-11-00招募中1 期
ong-Term Follow-Up of Subjects Treated With NTLA-2001 - ITL-2001-CL-999
Intellia Therapeutics Inc.0 个研究点目标入组 72 人开始时间: 2024年4月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •1. A participant has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received., 2. A participant has provided informed consent for the LTFU study., 3. A participant is willing to attend study visits, complete protocol-required follow-up schedule, and comply with the study requirements.
排除标准
- 未提供
研究者
相似试验
招募中
1 期
ong-Term Follow-Up of Subjects Treated With NTLA-2002MedDRA version: 20.0Level: PTClassification code: 10019860Term: Hereditary angioedema Class: 100000004850Hereditary AngioedemaCTIS2023-507956-56-00Intellia Therapeutics Inc.29
Unknown
不适用
Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002Hereditary AngioedemaNCT06262399Intellia Therapeutics100
Enrolling By Invitation
不适用
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001Transthyretin-Related (ATTR) Familial Amyloid PolyneuropathyTransthyretin-Related (ATTR) Familial Amyloid CardiomyopathyWild-Type Transthyretin Cardiac AmyloidosisNCT05697861Intellia Therapeutics72
已完成
不适用
ong-term stability after Class II treatment with the Herbst applianceClass II malocclusion (stability after treatment)K07Dentofacial anomalies [including malocclusion]DRKS00006354Justus-Liebig-Universität GiessenPoliklinik für Kieferorthopädie72
已完成
不适用
ong-term stability after Class II treatment with the Herbst appliance after the end of growthClass II malocclusion (long-term stability after treatment)K07Dentofacial anomalies [including malocclusion]DRKS00023022Justus-Liebig-Universität Giessen Poliklinik für Kieferorthopädie33